Łabuz, Grzegorz
Rayamajhi, Asu
Komar, Katarzyna
Khoramnia, Ramin
Auffarth, Gerd U.
Funding for this research was provided by:
National Science Centre (2016/23/B/ST2/00752)
Klaus Tschira Stiftung (00.290.2016)
Universitätsklinikum Heidelberg
Article History
Received: 16 June 2021
Accepted: 13 December 2021
First Online: 4 February 2022
Competing interests
: G. U. Auffarth reports grants, personal fees, non-financial support and consulting fees from Johnson&Johnson and Alcon, grants, personal fees, and non-financial support from Carl Zeiss Meditec, Hoya, Kowa, Oculentis/Teleon, Rayner, Santen, Sifi, Ursapharm, grants, and personal fees from Biotech, Oculus, EyeYon grants from Acufocus, Anew, Contamac, Glaukos, Physiol, Rheacell, outside the submitted work. R. Khoramnia reports grants, personal fees, and non-financial support from Alcon, Johnson&Johnson, Hoya, Physiol, Rayner, personal fees, and non-financial support from Kowa, Ophtec, Oculentis/Teleon, Santen, and Acufocus, outside the submitted work. K. Komar is a co-author of U.S. patent 10856734 owned by Polgenix Inc. for “Systems and methods of infrared psychophysical measurement”. G. Łabuz and A. Rayamajhi have nothing to disclose.